Skip to main navigation
Skip to content

Salarius

Live - Corporate Menu

  • About Us
    • Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisors
  • Our Programs
    • Epigenetics
    • LSD1
    • Pipeline
    • Publications
    • Clinical Trials
  • News & Events
    • Press Releases
    • Upcoming Events
    • In the News
  • Investors
    • Overview
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
    • Press Releases
    • In The News
    • Financial Reports
      • Annual Reports
      • Quarterly & Other Reports
      • Tax Documents
    • SEC Filings
    • Events & Presentations
    • Investor Resources
      • Investor FAQS
      • Information Request
      • E-Mail Alerts
      • Contact IR
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Price Lookup
    • Analyst Coverage
  • Contact Us
Search

PRESS RELEASES

PRESS RELEASES

Keyword Search

January 21, 2021

Salarius Pharmaceuticals Regains Compliance with N...

HOUSTON , Jan. 21, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc . (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that it has received a letter from the
January 15, 2021

Salarius Pharmaceuticals Announces Dr. Daniela San...

HOUSTON , Jan. 15, 2021 (GLOBE NEWSWIRE) -- Salarius Pharm aceuticals, Inc . (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that Daniela Y.
January 13, 2021

Salarius Pharmaceuticals Receives Second Installme...

HOUSTON , Jan. 13, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc . (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, today announced the receipt of a $0.9 million payment as

Investor Tools

Salarius

Footer Nav

  • About Us
    • Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisors
  • Our Programs
    • Epigenetics
    • LSD1
    • Pipeline
    • Publications
    • Clinical Trials
  • News & Events
    • Press Releases
    • Upcoming Events
    • In the News
  • Investors
    • Overview
    • Corporate Governance
    • Press Releases
    • In The News
    • Events & Presentations
    • Financial Reports
    • Investor Resources
    • Stock Information
    • Analyst Coverage
  • Contact Us

Live - Social Icons

  • Connect on Facebook
  • Connect on Twitter
  • Connect on Linkedin
© 2021 Salarius Pharmaceuticals, Inc. All Rights Reserved.

Live - Footer

  • Privacy and Terms of Use